State Of Tennessee, Treasury Department Nektar Therapeutics Transaction History

State Of Tennessee, Treasury Department

$26.5 Billion
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.64 - $3.15 $6,426 - $31,632	-10,042 Reduced 13.59%	63,869 $44,000
Q3 2022 Jan 26, 2023	BUY	$3.04 - $5.14 $10,284 - $17,388	3,383 Added 4.8%	73,911 $237,000
Q1 2022 May 11, 2022	SELL	$4.16 - $13.72 $579,537 - $1.91 Million	-139,312 Reduced 66.39%	70,528 $380,000
Q4 2021 Feb 15, 2022	BUY	$10.83 - $18.41 $2.27 Million - $3.86 Million	209,840 New	209,840 $2.84 Million
Q3 2021 Nov 12, 2021	SELL	$13.07 - $18.84 $1.96 Million - $2.83 Million	-150,000 Closed	0 $0

Q1 2021 May 10, 2021	BUY	$16.56 - $25.46 $2.48 Million - $3.82 Million	150,000 New	150,000 $3 Million
Q3 2020 Nov 16, 2020	SELL	$16.59 - $24.79 $2.31 Million - $3.45 Million	-139,269 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$16.86 - $23.44 $168,869 - $234,775	-10,016 Reduced 6.71%	139,269 $3.23 Million
Q1 2020 May 15, 2020	BUY	$14.47 - $27.96 $2.16 Million - $4.17 Million	149,285 New	149,285 $2.67 Million
Q4 2019 Feb 06, 2020	SELL	$15.87 - $23.12 $690,313 - $1.01 Million	-43,498 Closed	0 $0
Q3 2019 Oct 30, 2019	BUY	$16.91 - $36.27 $56,344 - $120,851	3,332 Added 8.3%	43,498 $792,000
Q2 2019 Aug 12, 2019	SELL	$31.0 - $36.3 $105,338 - $123,347	-3,398 Reduced 7.8%	40,166 $1.43 Million
Q1 2019 May 13, 2019	SELL	$31.58 - $46.35 $40,706 - $59,745	-1,289 Reduced 2.87%	43,564 $1.46 Million
Q4 2018 Feb 11, 2019	SELL	$30.43 - $56.65 $387,799 - $721,947	-12,744 Reduced 22.13%	44,853 $1.47 Million
Q3 2018 Nov 13, 2018	BUY	$46.46 - $68.49 $901,602 - $1.33 Million	19,406 Added 50.81%	57,597 $3.51 Million
Q2 2018 Aug 14, 2018	SELL	$46.25 - $104.45 $695,738 - $1.57 Million	-15,043 Reduced 28.26%	38,191 $1.87 Million
Q1 2018 May 11, 2018	SELL	$57.4 - $108.44 $4 Million - $7.56 Million	-69,686 Reduced 56.69%	53,234 $5.66 Million
Q4 2017 Feb 12, 2018	SELL	$23.02 - $60.5 $280,498 - $737,192	-12,185 Reduced 9.02%	122,920 $7.34 Million
Q3 2017 Nov 01, 2017	BUY	$17.79 - $24.0 $2.4 Million - $3.24 Million	135,105	135,105 $3.24 Million

Others Institutions Holding NKTR

# of Institutions

128

Shares Held

111M

Call Options Held

150K

Put Options Held

Deep Track Capital, LP Greenwich, CT

18.4M
Shares

$21.5 Million
0.57% of portfolio
Vanguard Group Inc Valley Forge, PA

12M
Shares

$14.1 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

7.57M
Shares

$8.86 Million
0.02% of portfolio
Primecap Management CO Pasadena, CA

6.97M
Shares

$8.15 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.88M
Shares

$6.88 Million
0.0% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

News

Stay updated on State Of Tennessee, Treasury Department with notifications on news.

Account